FindTrial
Sign In

Two ways of giving erector spinae plane block for pain relief after surgery in patients undergoing breast surgeries

Parasagittal versus transverse approaches of erector spinae plane block for post operative analgesia in patients undergoing modified radical mastectomy-A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041615
Enrollment
78
Registered
2022-04-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C501- Malignant neoplasm of central portion of breast Health Condition 2: C501- Malignant neoplasm of central portion of breast

Interventions

Intervention1: Transverse approach of Erector Spinae Plane Block: USG guided transverse approach of erector spinae plane block using 22G 80mm needle at T3 level Control Intervention1: Parasagittal app

Sponsors

Lady Hardinge Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients planned for modified radical mastectomy.

Exclusion criteria

Exclusion criteria: 1.Any known allergy to the drugs used 2.Contraindication to nerve block like coagulopathy,bleeding diathesis and local infections

Design outcomes

Primary

MeasureTime frame
Mean opioid consumption (in mg/kg) at 24 hours postoperatively in both the groupsTimepoint: at 24 hour post-operatively—

Secondary

MeasureTime frame
1. Total number of skin puncture to perform the block. 2. Proportion of patients developing complications related to block like hematoma, pleural puncture etc 3. Mean duration in minutes taken for completion of block from initial needle entry to completion of block. 4. Numerical rating scale (NRS) at 0,6,12 and 24 hours postoperatively.Timepoint: 0, 6, 12 and 24 hours—

Countries

India

Contacts

Public ContactNitin Hayaran

Lady hardinge medical college

sakshikiran003@gmail.com6200612553

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026